MSF welcomes Colombia taking a historic next step towards issuing first-ever compulsory license to increase access to more affordable generic versions of key HIV medicine dolutegravir

MSF urges ViiV to withdraw problematic purchasing conditions hindering access to HIV prevention drug CAB-LA

CAB-LA is a game-changing HIV prevention medicine, but access to it is currently a challenge.

MSF warned that access to point-of-care CD4 tests for HIV are under threat because Abbott and Becton Dickinson have decided to stop production

With affordable generics likely years away, ViiV must make information public on supply of long-acting cabotegravir and global distribution plan to ensure access for people in high HIV burden low- and middle-income countries

MSF calls on ViiV to urgently dismantle barriers to access for long-acting cabotegravir

Thousands of deaths from a fungal infection of the brain called cryptococcal meningitis (CM) could potentially be averted every year in South Africa if an antifungal medicine called flucytosine is widely available.

It is unacceptable that people living with HIV are still dying because the tests, treatment and care for life-threatening infections are not available.

Regarding the text of the declaration for the upcoming UN High-Level Meeting (HLM) on HIV/AIDS, MSF released this statement urging all countries to recognise and retain the full rights and use of international public health safeguards ...

UNAIDS released today its 2020 Global AIDS Update Report. MSF joins UNAIDS in calling for countries to implement practices to help mitigate the impact of COVID-19 on HIV treatment services.

Eswatini has the highest percentage of people living with HIV in the world. Almost one-thirds of adults are HIV-positive. The country is also severely affected by a tuberculosis (TB) epidemic and around 70% of all TB patients are co ...

Present in the country since 2007, MSF has adapted the way it treats people with HIV and TB in times of COVID-19. In this video, Michelle Daka, MSF Nurse Activity Manager, explains the innovative and creative approaches MSF teams are ...

After a decade of strong commitments to fight the twin epidemics of HIV and tuberculosis (TB), a decline in international funding and the rapid shifting of the financial burden to affected countries is in danger of reversing lifesaving ...

A combination of generic drugs coupled with a comprehensive patient support model has shown promising results in a pilot project run by Médecins Sans Frontières (MSF) in Ukraine.